Chemical activators of proline rich 30 utilize various cellular pathways to modulate the protein's activity. Bisindolylmaleimide I operates by inhibiting protein kinase C (PKC), a negative regulator of proline rich 30. When PKC activity is reduced, the suppression it exerts on proline rich 30 is lifted, resulting in the protein's activation. Similarly, PMA directly stimulates PKC, which can then phosphorylate and activate proline rich 30. Forskolin, by elevating intracellular cAMP levels, leads to the activation of protein kinase A (PKA). Activated PKA can phosphorylate proline rich 30, thus enhancing its activity. Dibutyryl cAMP, a cAMP analog, also activates PKA, achieving the same effect. Ionomycin raises intracellular calcium levels, which activate calcium-dependent protein kinases that can phosphorylate and trigger proline rich 30.
Furthermore, the compound okadaic acid, by inhibiting phosphatases like PP1 and PP2A, prevents the dephosphorylation of proteins, thereby maintaining proline rich 30 in a phosphorylated and active state. Anisomycin activates stress-activated protein kinases such as JNK, which are known to phosphorylate certain proteins, possibly including proline rich 30. Calyculin A, another phosphatase inhibitor, similarly promotes the phosphorylation state of proteins, including proline rich 30. Thapsigargin's mechanism involves the inhibition of the SERCA pump, leading to increased cytosolic calcium levels which can initiate signaling cascades that activate proline rich 30. Staurosporine, although a PKC inhibitor, can at low concentrations activate other kinases that may target and activate proline rich 30. Epigallocatechin Gallate, by inhibiting certain protein kinases, can lead to the activation of alternate kinases which may then phosphorylate proline rich 30. Lastly, sphingosine, by inhibiting PKC, can remove inhibitory phosphorylations on proline rich 30, resulting in its activation. Each chemical, through its unique interaction with cellular signaling pathways, can contribute to the regulatory control of proline rich 30's activity state.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a specific protein kinase C (PKC) inhibitor that, paradoxically, can activate proline rich 30 by inhibiting PKC which may otherwise maintain proline rich 30 in an inactive state through negative feedback mechanisms. By inhibiting PKC, Bisindolylmaleimide I removes this inhibitory effect, leading to the activation of proline rich 30. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium concentration, which can activate calcium-dependent protein kinases that, in turn, phosphorylate and activate proline rich 30. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) directly activates PKC, which can phosphorylate and activate proline rich 30 as part of downstream signaling events. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels within the cell. This can result in the enhanced phosphorylation and activation of proline rich 30. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases such as JNK, which can phosphorylate targets including proline rich 30, leading to its activation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of serine/threonine protein phosphatases. By inhibiting these phosphatases, it can increase the phosphorylation state of proteins, including proline rich 30, effectively activating it. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels which can activate pathways that phosphorylate and activate proline rich 30. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP is a cell-permeable cAMP analog that activates PKA, leading to the phosphorylation and activation of proline rich 30. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent PKC inhibitor but can also nonspecifically activate other kinases at low concentrations. This nonspecific kinase activation may phosphorylate and activate proline rich 30. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate is known for its ability to inhibit various protein kinases, but the resulting imbalance in kinase activity can lead to compensatory activation of other kinases which could phosphorylate and thereby activate proline rich 30. | ||||||